The report, not made public, was commissioned by the main US pharmaceutical lobby, the Pharmaceutical Research and ...

Donald Trump's healthcare revamp, emphasizing generics and biosimilars, could boost Indian drug makers, who already supply 40 ...

The Trump administration’s threat of pharmaceutical tariffs could risk significant political backlash, as the drug industry ...

European drugmakers are urging the EU to allow higher medicine prices, warning that without stronger investment incentives, ...

Following trade suspension with India, Pakistani health authorities are taking "emergency preparedness" steps to secure ...

The analysis, conducted by Ernst & Young, found the United States imported $203 billion in pharmaceutical products in 2023, ...

Big Pharma continues fighting nationwide to block access to a vital drug program ― including here in Oklahoma.

Pharmaceutical companies in Europe are requesting the EU to adopt drug pricing strategies comparable to the US.

Drugmakers have been warned that the Trump Administration is considering linking U.S. medicine prices to lower amounts paid ...

The Trump administration is proceeding with probes into the national security implications of pharmaceutical imports.

The analysis, conducted by Ernst & Young, found the United States imported $203 billion in pharmaceutical products in 2023 ...

The pharmaceutical industry's next billion-dollar blockbuster won't come from a lab alone—it will come from listening to ...